Age‐Related Alterations of the Growth Hormone/Insulin‐Like‐Growth‐Factor I Axis
1991; Wiley; Volume: 39; Issue: 3 Linguagem: Inglês
10.1111/j.1532-5415.1991.tb01654.x
ISSN1532-5415
Autores Tópico(s)Genetic Syndromes and Imprinting
ResumoJournal of the American Geriatrics SocietyVolume 39, Issue 3 p. 295-307 Geriatric Bioscience Age-Related Alterations of the Growth Hormone/Insulin-Like-Growth-Factor I Axis Mirtha Kelijman MD, Corresponding Author Mirtha Kelijman MDAddress correspondence and reprint requests to Mirtha Kelijman, MD, Division of Geriatric Medicine, 1402 S. Grand Blvd., Room M-238, St. Louis, Missouri 63104.Search for more papers by this author Mirtha Kelijman MD, Corresponding Author Mirtha Kelijman MDAddress correspondence and reprint requests to Mirtha Kelijman, MD, Division of Geriatric Medicine, 1402 S. Grand Blvd., Room M-238, St. Louis, Missouri 63104.Search for more papers by this author First published: March 1991 https://doi.org/10.1111/j.1532-5415.1991.tb01654.xCitations: 103 From the Geriatric Research Education and Clinical Center, Departments of Veterans Affairs Medical Center, St. Louis, Missouri and the Division of Geriatric Medicine, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, Missouri. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Frohman LA. Diseases of the anterior pituitary. In P Felig, JD Baxter, AE Broadus, LA Frohman eds. Endocrinology and Metabolism. New York: McGraw-Hill, 1987. 2Jorgensen JOL, Thuesen L, Ingemann-Hansen T, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1: 1221–1225. 3Salomon F, Cuneo RC, Hesp R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321: 1797–1803. 4Goeddel DV, Heyreker HL, Hozumi T, et al. Direct expression in E. Coli of a DNA sequence coding for human growth hormone. Nature 1979; 281: 554–558. 5Hintz RL, Rosenfeld RG, Wilson DM, et al. Biosynthetic methionyl human growth hormone is biologically active in adult man. Lancet 1982; 1: 1276–1279. 6Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990; 70: 519–527. 7Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1–6. 8Kaiser FE, Silver AJ, Strome LS, Morley JE. The effect of growth hormone on malnourished elderly (abstract). 42nd Annual Scientific Meeting “Aging differently.” Gerontologist 1989; 29: 222A–223A. 9Binnerts A, Wilson JHP, Lamberts SWJ. The effects of human growth hormone administration in elderly adults with recent weight loss. J Clin Endocrinol Metab 1988; 67: 1312–1316. 10Aloia JF, Vaswani A, Meunier PJ, et al. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 1987; 40: 253–259. 11Aloia JF, Vaswani A, Kapoor A, et al. Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 1985; 34: 124–129. 12Rudman D. Occasional hypothesis: Growth hormone, body composition, and aging. J Am Geriatr Soc 1985; 33: 800–807. 13Tannenbaum GS, Martin JB. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 1976; 98: 562–570. 14Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 1985; 230: 461–463. 15Wehrenberg WB, Brazeau P, Ling N, et al. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Endocrinology 1984; 114: 1613–1616. 16Wehrenberg WB, Brazeau P, Luben R, et al. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 1982; 111: 2147–2148. 17Ferland L, Labrie F, Jobin M, et al. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun 1976; 68: 149–156. 18Tannenbaum GS, Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 1984, 115: 1952–1957. 19Muller EE: Neural control of somatotropic function. Physiol Rev 1987; 67: 962–1053. 20Takahashi Y, Kipnis DM, Daughaday WH: Growth hormone secretion during sleep. J Clin Invest 1968; 47: 2079–2090. 21Honda Y, Takahashi K, Takahashi S, et al. Growth hormone secretion during nocturnal sleep in normal subjects. J Clin Endocrinol Metab 1969; 29: 20–29. 22Parker DC, Sassin JF, Mace JW, et al. Human growth hormone release during sleep: electroencephalographic correlation. J Clin Endocrinol Metab 1969; 29: 871–874. 23Sassin JF, Parker DC, Mace JW, et al. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science 1969; 165: 513–515. 24Vance ML, Kaiser DL, Evans WS, et al. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1–40). J Clin Invest 1985; 75: 1584–1590. 25Sassolas G, Garry J, Cohen R, et al. Nocturnal continuous infusion of growth hormone (GH)-releasing hormone results in a dose-dependent accentuation of episodic GH secretion in normal men. J Clin Endocrinol Metab 1986; 63: 1016–1022. 26Vance ML, Kaiser DL, Evans WS, et al: Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusion of GHRH on GH secretion in normal man. J Clin Endocrinol Metab 1985, 60: 370–374. 27Salmon WD Jr, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957; 49: 825–836. 28D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984; 81: 935–939. 29Schoenle E, Zapf J, Humbel RE, et al. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 1982; 296: 252–253. 30Guler H-P, Zapf J, Scheiwiller E, et al. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889–4893. 31Isgaard J, Nilsson A, Lindahl A, et al. Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 1986; 250: E367–E372. 32Schlechter NL, Russell SM, Spencer EM, et al: Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986; 83: 7932–7934. 33Sonntag WE, Steger RW, Forman LJ, et al. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 1980; 107: 1875–1879. 34Sonntag WE, Forman LJ, Miki N, et al. L-Dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats. Neuroendocrinology 1982; 34: 163–168. 35Takahashi S, Gottschall PE, Quigley KL, et al. Growth hormone secretory patterns in young, middle-aged and old female rats. Neuroendocrinology 1987; 46: 137–142. 36Forman LJ, Sonntag WE, Hylka VW, et al. Pituitary growth hormone and hypothalamic somatostatin in young female rats versus old constant estrous female rats. Experientia 1985; 41: 653–654. 37Florini JR, Harned JA, Richman RA, et al. Effect of rat age on serum levels of growth hormone and somatomedins. Mech Ageing Dev 1981; 15: 165–176. 38Goya RG, Sosa YE, Meites J. Half-life of plasma growth hormone in young and old conscious female rats. Exp Gerontol 1987; 22: 27–36. 39Solomon J, Greep RO. Relationship between pituitary growth hormone content and age in rats. Proc Soc Exp Biol Med 1958; 99: 725–727. 40Bowman RH. Growth hormone activity of the anterior pituitary lobe of the male rat at various ages. Nature 1961; 192: 976–977. 41Burek CL, Frohman LA. Growth hormone synthesis by rat pituitaries in vitro: effect of age and sex. Endocrinology 1970; 86: 1361. 42Billestrup N, Swanson LW, Vale W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 1986; 83: 6854–6857. 43Fukata J, Diamond DJ, Martin JB. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology 1985; 117: 457–467. 44Pecile A, Muller E, Falconi G, et al. Growth hormone-releasing activity of hypothalamic extracts at different ages. Endocrinology 1965; 77: 241–246. 45Morimoto N, Kawakami F, Makino S, et al. Age-related changes in growth hormone releasing factor and somatostatin in the rat hypothalamus. Neuroendocrinology 1988; 47: 459–464. 46Ge F, Tsagarakis S, Rees LH, et al. Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic explants. J Endocrinol 1989; 123: 53–58. 47De Gennaro Colonna V, Zoli M, Cocchi D, et al. Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. Peptides 1989; 10: 705–708. 48Sonntag WE, Hylka VW, Meites J. Impaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hpGRF(1–44). Endocrinology 1983; 113: 2305–2307. 49Sonntag WE, Gough MA. Growth hormone releasing hormone induced release of growth hormone in aging male rats: dependence on pharmacological manipulation and endogenous so matostatin release. Neuroendocrinology 1988; 47: 482–488. 50Ceda GP, Valenti G, Butturini U, et al. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats. Endocrinology 1986; 118: 2109–2114. 51Parenti M, Dall'ara A, Rusconi L, et al. Different regulation of growth hormone-releasing factor-sensitive adenylate cyclase in the anterior pituitary of young and aged rats. Endocrinology 1987; 121: 1649–1653. 52Sonntag WE, Forman LJ, Miki N, et al. Effects of CNS active drugs and somatostatin antiserum on growth hormone release in young and old male rats. Neuroendocrinology 1981, 33: 73–78. 53Cocchi D, Calderini G, Ganzetti I, et al. Aspects of the control of prolactin and growth hormone secretion in aging, in EE Muller, RM MacLeod (eds): Neuroendocrine Perspectives. Amsterdam, The Netherlands, Elsevier Science, 1986, p 191–204. 54Locatelli V, Arimura A, Torsello A, et al. Somatostatin anti serum antagonizes the impaired ability of hpGRF-40 to stimulate growth hormone release in old unanesthetized male rats. Neuroendocrinol Lett 1984; 6: 261–266. 55Wehrenberg WB, Ling N, Brazeau P, et al. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochem Biophys Res Commun 1982; 109: 382–387. 56Wehrenberg WB, Ling N. The absence of an age-related change in the pituitary response to growth hormone-releasing factor in rats. Neuroendocrinology 1983; 37: 463–466. 57Hoffman GE, Sladek JR Jr. Age-related changes in dopamine, LHRH and somatostatin in the rat hypothalamus. Neurobiol Aging 1980; 1: 27–37. 58Sonntag WE, Gottschall PE, Meites J. Increased secretion of somatostatin-28 from hypothalamic neurons of aged rats in vitro. Brain Research 1985; 380: 229–234. 59Katakami H, Downs TR, Frohman LA. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Endocrinology 1988, 123: 1103–1109. 60Simpkins JW, Mueller GP, Huang HH, et al. Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: possible relation to gonadotropin secretion. Endocrinology 1977; 100: 1672–1678. 61Lima L, Dall'ara A, Parenti M, et al. Replenishment of brain catecholamine stores does not restore the impaired growth hormone (GH) responsiveness to GHRH in aged rats. Pharmacol Res 1989; 21: 87–88. 62Florini JR, Roberts SB. Effect of rat age on blood levels of somatomedin-like growth factors. J Gerontol 1980; 35: 23–30. 63Takahashi S, Meites J. GH binding to liver in young and old female rats: relation to somatomedin-C secretion. Proc Soc Exp Biol Med 1987, 186: 229–233. 64Nogens Blichert-Taft. Somatotrophin concentrations in blood under basal conditions. Acta Endocrinologica 1975;(Suppl 195): 60–68. 65Utiger RD. Extraction and radioimmunoassay of growth hormone in human serum. J Clin Endocrinol & Metab 1964, 24: 60–67. 66Carlson HE, Gillin JC, Gorden P, et al. Absence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly. J Clin Endocrinol Metab 1972; 34: 1102–1105. 67Finkelstein JW, Roffwarg HP, Boyar RM. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972; 35: 665–670. 68Prinz PN, Weitzman ED, Cunningham GR. Plasma growth hormone during sleep in young and aged men. J Gerontol 1983; 38: 519–524. 69Zadik Z, Chalew SA, McCarter RJ Jr, et al. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985; 60: 513–516. 70Rudman D, Kutner MH, Rogers CM, et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361–1369. 71Vermeulen A. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab 1987; 64: 884–888. 72Taylor AL, Finster JL, Mintz DH. Metabolic clearance and production rates of human growth hormone. J Clin Invest 1969; 48: 2349–2358. 73Gershberg H. Growth hormone content and metabolic actions of human pituitary glands. Endocrinology 1957; 61: 160–165. 74Pasteels JL, Gausset P, Danguy A, et al. Morphology of the lactotropes and somatotropes of man and rhesus monkeys. J Clin Endocrinol Metab 1972; 34: 959–967. 75Calderon L, Ryan N, Kovacs K. Human pituitary growth hormone cells in old age. Gerontology 1978; 24: 441–447. 76Sun Y-K, Xi Y-P, Fenoglio CM, et al. The effect of age on the number of pituitary cells immunoreactive to growth hormone and prolactin. Human Pathology 1984; 15: 169–180. 77Shibasaki T, Shizume K, Nakahara M, et al. Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 1984; 58: 212–214. 78Franchimont P, Urbain-Choffray D, Lambelin P, et al. Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like grwoth factor I, and bone metabolism in postmenopausal women. Acta Endocrinologica 1989; 120: 121–128. 79Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989; 69: 910–913. 80Lang I, Schernthaner G, Pietschmann P, et al. Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab 1987; 65: 535–540. 81Giusti M, Lomeo A, Marini G, et al. Role of aging on growth hormone and prolactin release after growth hormone-releasing hormone and domperidone in man. Hormone Res 1987; 27: 134–140. 82Pavlov EP, Harman SM, Merriam GR, et al. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986; 62: 595–600. 83Leppaluoto J, Tapanainen P, Knip M: Heat exposure elevates plasma immunoreactive growth hormone-releasing hormone levels in man. J Clin Endocrinol Metab 1987; 65: 1035–1038. 84Lai S, Nair NPV, Thavundayil JX, et al. Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type. Neurobiology of Aging 1989; 10: 227–231. 85Shibasaki T, Hotta M, Masuda A, et al. Plasma GH responses to GHRH and insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 1985; 60: 1265–1267. 86Masuda A, Shibasaki T, Hotta M, et al. Different mechanisms for GH secretion are present in GH stimulation tests in man. 70th Annual Meeting of The Endocrine Society, New Orleans LA, 1988 (Abstract 104) p 46. 87Kelijman M, Frohman LA. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion. J Clin Endocrinol Metab 1988; 66: 872–875. 88Kashio Y, Chihara K, Kita T, et al. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extra-hypothalamic tissue. J Clin Endocrinol Metab 1987; 64: 92–97. 89Rosskamp R, Schmid G, Klumpp J, et al. Insulin hypoglycemia but not arginine infusions stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children. Horm Metabol Res 1987; 19: 434–436. 90Tapanainen P, Knip M, Lautala P, et al. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-Dopa, and insulin in normal men. J Clin Endocrinol Metab 1988; 67: 845–849. 91Kalk WJ, Vinik AI, Pimstone BL, et al. Growth hormone response to insulin hypoglycemia in the elderly. J Gerontol 1973; 28: 431–433. 92Muggeo M, Fedele D, Tiengo A, et al. Human growth hormone and Cortisol response to insulin stimulation in aging. J Gerontol 1975; 39: 546–551. 93Wakabayashi I, Shibasaki T, Ling N. A divergence of plasma growth hormone response between growth hormone-releasing factor and insulin-induced hypoglycaemia among middle-aged healthy male subjects. Clin Endocrinol 1986; 24: 279–283. 94Alba-Roth J, Muller OA, Schopohl J, et al. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 1988; 67: 1186–1189. 95Page MD, Dieguez C, Valcavi R, et al. Growth hormone (GH) responses to arginine and L-Dopa alone and after GHRH pretreatment. Clin Endocrinol 1988; 28: 551–558. 96Dudl RJ, Ensinck JW, Palmer HE, et al. Effect of age on growth hormone secretion in man. J Clin Endocrinol Metab 1973; 37: 11–16. 97Blichert-Toft M. Stimulation of the release of corticotrophin and somatotrophin by metyrapone and arginine. Acta Endocrinologica, Suppl 1975; 195: 65–85. 98Valcavi R, Dieguez C, Page MD, et al. AIpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects. Clin Endocrinol 1988; 29: 309–316. 99Brion DE, Donnadieu M, Liapi C, et al. Plasma growth hormone releasing factor levels in children: physiological and pharmacologically induced variations. Hormone Res 1986; 24: 116–120. 100Miki N, Ono M, Shizume K. Evidence that opiatergic and α-adrenergic mechanisms stimulate rat growth hormone release via growth hormone releasing factor (GRF). Endocrinology 1984; 114: 1950–1952. 101Kabayama Y, Kato Y, Murakami Y, et al. Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus. Endocrinology 1986; 119: 432–434. 102Gil-Ad I, Gurewitz R, Marcovici O, et al. Effect of aging on human plasma growth hormone response to clonidine. Mech Ageing Dev 1984; 27: 97–100. 103Matussek N, Ackenheil M, Hippius H, et al. Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 1980; 2: 25–36. 104Tulandi T, Lal S, Guyda H. Effect of estrogen on the growth hormone response to the α-adrenergic agonist clonidine in women with menopausal flushing. J Clin Endocrinol Metab 1987; 65: 6–10. 105Spellacy WN, Carlson KI, Schade SI. Human growth hormone levels in normal subjects receiving an oral contraceptive. JAMA 1967; 202: 451–454. 106Wiedemann E, Schwartz E, Frantz AG. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man. J Endocrinol Metab 1976; 42: 942–952. 107Dawson-Hughes B, Stern D, Goldman J, et al. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986; 63: 424–432. 108Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64: 51–58. 109Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986; 63: 1418–1420. 110Tenover JS, Matsumoto AM, Plymate SR, et al. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 1987; 65: 1118–1126. 111Kaiser FE, Viosca SP, Morley JE, et al. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc 1988; 36: 511–519. 112Rudman D, Nagraj HS, Mattson DE, et al. Hyposomatomedinemia in the nursing home patient. J Am Geriatr Soc 1986; 34: 427–430. 113Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986; 63: 651–655. 114Bennett AE, Wahner HW, Riggs BL, et al. Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 1984; 59: 701–704. 115Florini JR, Prinz PN, Vitiello MV, et al. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 1985; 40: 2–7. 116Johanson AJ, Blizzard RM. Low somatomedin-C levels in older men rise in response to growth hormone administration. The Johns Hopkins Medical Journal 1981; 149: 115–117. 117Wiedemann E, Schwartz E. Suppression of growth hormone-dependent human serum sulfation factor by estrogen. J Clin Endocrinol Metab 1972; 34: 51–58. 118Frohlander N, von Schoultz B. Growth hormone and somatomedin C during postmenopausal replacement therapy with oestrogen alone and in combination with an antioestrogen. Maturitas 1988; 9: 297–302. 119Berelowitz M, Szabo M, Frohman LA, et al. Somatomedin-C mediates growth hormone negative feedback by effects on the the hypothalamus and the pituitary. Science 1981; 212: 1279–1281. 120Bray GA: Obesity, an endocrine perspective, in LJ DeGroot (ed): Endocrinology, Vol II. Philadelphia, W.B. Saunders, 1989, pp 2303–2337. 121Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970; 19: 653–663. 122Meistas MT, Foster GV, Margolis S, et al. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982; 31: 1224–1228. 123Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity: A pituitary defect reversed with weight reduction. N Eng J Med 1984; 311: 1403–1407. 124Clemmons DR, Klibanski A, Underwood LE, et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 1247–1250. 125Morley JE. Nutrition in the Elderly. Ann Intern Med 1988; 109: 890–904. 126Raghuramulu N, Jaya Rao KS. Growth hormone secretion in patient-calorie malnutriton. J Clin Endocrinol Metab 1974; 38: 176–180. 127Hintz RL, Suskind R, Amatayakul K, et al. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrieion. J Pediatr 1978; 92: 153–156. 128Grant DB, Hambley J, Becker D, et al. Reduced sulphation factor in undernourished children. Arch Dis Child 1973; 48: 596–600. 129Silver AJ, Morley JE, Strome LS, et al. Nutritional status in an academic nursing home. J Am Geriatr Soc 1988; 36: 487–491. 130Rudman D, Nagraj HS, Mattson DE, et al. Hyposomatomedinemia in the men of a veterans administration nursing home: prevalence and correlates. Gerontology 1987; 33: 307–314. 131Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982; 55: 999–1002. 132Morley JE, Mooradian AD, Rosenthal MJ, et al. Diabetes mellitus in elderly patients. Am J Med 1987; 83: 533–544. 133Merimee TJ, Burgess JA, Rabinowitz D. Arginine infusion in maturity-onset diabetes mellitus. Lancet 1966; 1: 1300–1301. 134Burday SZ, Fine PH, Schalch DS. Growth hormone secretion in response to arginine infusion in normal and diabetic subjects: relationship to blood glucose levels. J Lab Clin Med 1968; 71: 897–911. 135Richards NT, Wood SM, Christofides ND, et al. Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1–44)] in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984; 27: 529–534. 136Pietschmann P, Schernthaner G. Effect of growth hormone releasing hormone on growth hormone secretion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 13–15. 137Pietschmann P, Schernthaner G, Prskavec F, et al. No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy. Diabetes 1987; 36: 159–162. 138Press M, Tamborlane WV, Thorner MO, et al. Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression. Diabetes 1984; 33: 804–806. 139Grecu EO, Spencer EM, White VA, et al. Exaggerated somatomedin-C response to human growth hormone infusion in patients with type II diabetes mellitus. Am J Med Sci 1984; 287: 7–10. 140Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whiekham survey. Clin Endocrinol 1977; 7: 481–493. 141Sawin CT, Chopra D, Azizi F, et al. The aging thyroid. JAMA 1979; 242: 247–250. 142Williams T, Maxon H, Thorner MO, et al. Blunted growth hormone (GH) response to GH-releasing hormone in hypothyroidism resolves in the euthyroid state. J Clin Endocrinol Metab 1985; 61: 454–456. 143Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2: 1403. 144Thienhaus OJ, Zemlan FP, Bienenfeld D, et al. Growth hormone response to edrophonium in Alzheimer's disease. Am J Psychiatry 1987; 144: 1049–1052. 145Davidson M, Davis BM, Bastiaens L, et al. Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects. Am J Psychiatry 1988; 145: 1007–1009. 146Blazer D, Williams CD. Epidemiology of dysphoria and depression in an elderly population. Am J Psychiatry 1980; 137: 439–443. 147Mendlewicz J, Linkowski P, Kerkhofs M, et al. Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 1985; 60: 505–512. 148Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-hour profiles of adrenocorticotropin, Cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987; 65: 141–152. 149Langer G, Heinze G, Reim B, et al. Reduced growth hormone responses to amphetamine in “endogenous” depressive patients. Arch Gen Psychiatry 1976; 33: 1471–1475. 150Gilles C, Ryckaert P, De Mol J, et al. Clonidine-induced growth hormone secretion in elderly patients with senile dementia of the Alzheimer type and major depressive disorder. Psychiatry Res 1989; 27: 277–286. 151Gruen PH, Sachar EJ, Altman N, et al. Growth hormone responses to hypoglycemia in postmenopausal depressed women. Arch Gen Psychiatry 1975; 32: 31–33. 152Lesch K-P, Laux G, Pfuller H, et al. Growth hormone (GH) response to GH-releasing hormone in depression. J Clin Endocrinol Metab 1987; 65: 1278–1281. 153Borges JCL, Gelato MC, Rogol AD, et al. Effects of human pancreatic tumor growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 1983; 2: 119–124. 154Thorner MO, Reschke J, Chitwood J, et al. Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 1985; 312: 4–9. 155Thorner MO, Vance ML, Rogol AD, et al. Some physiological and therapeutic considerations of GHRH in the regulation of growth. In O Isaksson, et al eds. Growth Hormone—Basic and Clinical Aspects. Amsterdam, The Netherlands, Elsevier Science, 1987, pp 153–162. 156Pontiroli AE, Perfetti MG, Fattor B, et al. Effect of intranasal growth hormone-releasing hormone and corticotropin-releasing hormone administration on growth hormone and Cortisol release: improved bioavailability by means of sodium-glycocholate. J Clin Endocrinol Metab 1989; 68: 821–824. Citing Literature Volume39, Issue3March 1991Pages 295-307 ReferencesRelatedInformation
Referência(s)